These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18900916)

  • 1. [Prophylaxis of metococcal disease].
    ROMAN ; LAFENETRE H
    Rev Pathol Comp; 1947; 47(591-592):449-63. PubMed ID: 18900916
    [No Abstract]   [Full Text] [Related]  

  • 2. [On a case of familial metococcal disease; metococcal seminal vesicle].
    TRAISSAC FJ; LAVIGNOLLE ; BELOT
    J Med Bord; 1947 Jun; 124(6):283-5. PubMed ID: 20255729
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatic determinations of metococcal disease about undulating icterus].
    MASSAL E
    Med Trop (Mars); 1948; 8(3):314-21. PubMed ID: 18873001
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of myelitis secondary to a metococcal disease].
    FRANCON F; DU LAC G
    Bull Med; 1945 Dec; 59():433. PubMed ID: 20983604
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metococcal osteoarthritis of the body].
    FORT P; BOLOT F
    Maroc Med; 1946; 25(260):95. PubMed ID: 20246559
    [No Abstract]   [Full Text] [Related]  

  • 6. [About the treatment of metococcal disease].
    FORISSIER M
    Concours Med; 1949 Jul; 71(28):1653. PubMed ID: 18134920
    [No Abstract]   [Full Text] [Related]  

  • 7. [An outline of prophylaxis adapted to local conditions, the purpose of an outbreak in melo, brucelósica the endemic region].
    GOMES FIGUEIRA M
    J Med (Oporto); 1948 Oct; 12(300):397-402. PubMed ID: 18894142
    [No Abstract]   [Full Text] [Related]  

  • 8. [Brucellosis control plan].
    AMUCHASTEGUI SR; DE VILLAFANE LASTRA T
    Rev Med Cordoba; 1947 Oct; 35(10):551-7. PubMed ID: 18899444
    [No Abstract]   [Full Text] [Related]  

  • 9. [Agglutination reactions with dried blood; application to serodiagnosis of typho-paratyphoid diseases, typhus and metococcal disease].
    DIACONO H
    Bull Soc Pathol Exot Filiales; 1947; 40(9-10):317-21. PubMed ID: 18921682
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bases and guidelines for the fight against human brucellosis in Spain].
    VEGA VILLALONGA J
    Rev Sanid; 1947 Apr; 21(4):361-84. PubMed ID: 20242128
    [No Abstract]   [Full Text] [Related]  

  • 11. Research progress in live attenuated Brucella vaccine development.
    Wang Z; Wu Q
    Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylaxis of animal brucellosis].
    MAGALLON
    Concours Med; 1953 Aug; 75(34):2879-81. PubMed ID: 13082973
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prophylaxis of human brucellosis].
    FAURE
    Concours Med; 1953 Aug; 75(34):2881-3. PubMed ID: 13082974
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current state of brucellosis prophylaxis].
    MOUSTARDIER G
    J Med Bord; 1952 Sep; 129(9):757-66. PubMed ID: 13023150
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prophylaxis of human brucellosis].
    SALVERAGLIO FJ
    Dia Med; 1957 Dec; 29(91):3410-2 passim. PubMed ID: 13501040
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of laboratory-acquired brucellosis: significant side effects of prophylaxis.
    Maley MW; Kociuba K; Chan RC
    Clin Infect Dis; 2006 Feb; 42(3):433-4. PubMed ID: 16392095
    [No Abstract]   [Full Text] [Related]  

  • 17. Confronting the barriers to develop novel vaccines against brucellosis.
    Oliveira SC; Giambartolomei GH; Cassataro J
    Expert Rev Vaccines; 2011 Sep; 10(9):1291-305. PubMed ID: 21919619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
    Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
    Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of laboratory-acquired brucellosis.
    Robichaud S; Libman M; Behr M; Rubin E
    Clin Infect Dis; 2004 Jun; 38(12):e119-22. PubMed ID: 15227634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic and protective antigens of Brucella as vaccine candidates.
    Masjedian Jezi F; Razavi S; Mirnejad R; Zamani K
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():29-36. PubMed ID: 31300122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.